COVID-19 in older adults: What are the differences with younger patients?

Ana B Gómez-Belda1, Mar Fernández-Garcés1, Elisabeth Mateo-Sanchis1

  • 1Department of Internal Medicine, Dr. Peset University Hospital, Valencia, Spain.

Insights

Older adults with coronavirus disease 2019 (COVID-19) present atypically, experience more complications, and face higher mortality rates. Low oxygen saturation on admission is a key predictor of death in this population.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease 2019 (COVID-19) disproportionately affects older adults.
  • Understanding the unique clinical presentation and risk factors in this demographic is crucial for effective management.

Purpose of the Study:

  • To delineate the distinct clinical characteristics of COVID-19 in older adults compared to younger patients.
  • To identify significant risk factors associated with mortality in elderly COVID-19 patients.

Main Methods:

  • A retrospective observational study was conducted at Doctor Peset University Hospital, Spain, involving patients admitted between March 11 and April 28, 2020.
  • COVID-19 diagnosis was confirmed via RT-PCR or serology.
  • Data collected included demographics, clinical presentation, laboratory findings, and complications from electronic medical records.

Main Results:

  • The study included 340 patients, with 152 (44.6%) over 70 years old. Older adults exhibited more comorbidities and atypical symptoms (e.g., confusion) but fewer typical COVID-19 symptoms.
  • Higher rates of acute respiratory distress syndrome (53.3% vs 33.2%), acute kidney injury (11.8% vs 5.3%), and mortality (28.9% vs 6.5%) were observed in older patients.
  • Low oxygen saturation (≤93%) on room air at admission was a significant predictor of mortality in older adults (OR 11.65, P < 0.001).

Conclusions:

  • Older adults with COVID-19 present with atypical symptoms, increased complications, and significantly higher mortality.
  • Oxygen saturation ≤93% on room air during admission is a critical prognostic indicator for mortality in elderly COVID-19 patients.
  • These findings underscore the need for vigilant monitoring and tailored management strategies for geriatric COVID-19 patients.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
104
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
81
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
115
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
150
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
105
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
93